Wednesday, September 11, 2002 1:00:35 PM
Best regards, Tom
Recent ADCT News
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024 • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma • GlobeNewswire Inc. • 04/04/2024 11:00:00 AM
- ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024 • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit • GlobeNewswire Inc. • 03/06/2024 12:15:00 PM
- ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/05/2024 10:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 02:15:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:37 PM
- ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 01:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:15:54 PM
- ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards • GlobeNewswire Inc. • 01/04/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:00:30 PM
- ADC Therapeutics Provides Business Updates • GlobeNewswire Inc. • 01/04/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 01:10:56 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 01:05:58 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 01:04:44 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 01:00:16 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:59:46 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:58:50 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM